Title:
HUMAN INDUCED PLURIPOTENT STEM CELL AND CULTURE METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/095298
Kind Code:
A1
Abstract:
Provided are a human induced pluripotent stem cell and a culture method therefor and a use thereof. The human induced pluripotent stem cell is obtained by transfecting a human pluripotent adipose-derived stem cell by using a human estrogen-related receptor γ gene and/or a human insulin gene, and can be used for preparing a drug for treating diabetes.
Inventors:
WANG TAIHUA (CN)
WANG XINGXIN (CN)
WANG XINGXIN (CN)
Application Number:
PCT/CN2021/075321
Publication Date:
May 12, 2022
Filing Date:
February 04, 2021
Export Citation:
Assignee:
SHANDONG NEW MEDICINE RES INSTITUTE OF INTEGRATED WESTERN MEDICINE AND TCM CO LTD (CN)
International Classes:
A61K35/545; C12N5/10; A61P3/10; C12N5/074; C12N15/12; C12N15/17
Domestic Patent References:
| WO2015148832A1 | 2015-10-01 | |||
| WO2016138464A1 | 2016-09-01 |
Foreign References:
| CN103191445A | 2013-07-10 | |||
| CN102066555A | 2011-05-18 | |||
| CN106566803A | 2017-04-19 |
Other References:
LIU XIAOYU, ZHANG TAO, WANG RUI, SHI PING, PAN BOCHEN, PANG XINING: "Insulin-Transferrin-Selenium as a Novel Serum-free Media Supplement for the Culture of Human Amnion Mesenchymal Stem Cells", ANNALS OF CLINICAL AND LABORATORY SCIENCE., INSTITUTE FOR CLINICAL SCIENCE, PHILADELPHIA, PA., US, vol. 49, no. 1, 28 February 2019 (2019-02-28), US , pages 63 - 71, XP055927977, ISSN: 0091-7370
Attorney, Agent or Firm:
BEIJING GUANGYOU PATENT OFFICE CO.LTD. (CN)
Download PDF:
Previous Patent: DECISION FEEDBACK EQUALIZER AND DATA ACQUISITION AND CORRECTION METHOD
Next Patent: CLEANING MACHINE
Next Patent: CLEANING MACHINE